Japan, April 1 -- JANSSEN BIOTECH INC has got intellectual property rights for 'SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES.' Other related details are as follows:

Application Number: JP,2023-182287

Category (FI): A61K31/255,A61K31/454,A61K31/5377,A61K31/573,A61K31/675,A61K31/69,A61K38/47,A61K39/395@N,A61K39/395@T,A61K45/00,A61K47/02,A61K47/12,A61K47/18,A61K47/20,A61K47/22,A61K47/26,A61K47/34,A61K9/08,A61P35/00,A61P35/02,A61P43/00,111,A61P43/00,121,C12N15/13

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Oct. 24, 2023

Publication Date: Jan. 23, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....